Stock Quote |
|
||||||||||||
0.01 (0.05%)
Corporate Profile
Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.
Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
More>>
More » Recent News
| Date | Title | |
|---|---|---|
| 06/06/13 |
DANVERS, Mass., June 6, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert L. Bowen, Vice President & CFO, will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Thursday, June 13, 2013 at 10:00 a.m. PDT. The conference will be held ... |
|
| 06/05/13 |
DANVERS, Mass., June 5, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the William Blair 33rd Annual Growth Stock Conference on Wednesday, June 12, 2013 at 8:40 a.m. CDT. The... |
|
| 05/28/13 |
DANVERS, Mass., May 28, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that the Netherlands has approved new reimbursement coding and payment for the Impella product. The new coding allows for hospitals to receive funding f... |
|
| 05/22/13 |
DANVERS, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Deutsche Bank 38th Annual Health Care Conference on Wednesday, May 29, 2013 at 2:50 p.m. E... |
|
| 05/17/13 |
DANVERS, Mass., May 17, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the UBS Global Health Care Conference on Wednesday, May 22, 2013 at 10:00 a.m. ET. The confere... |
|
Investor Relations
Investor Tools
|
|
Print Page |
|
E-mail Page |
|
RSS Feeds |
|
Snapshot |